Clinical trial
Aridol Challenge as a Tool to Predict Treatment Response to Inhaled…
NCT00117182 · Syntara, Industry · Completed
Key facts
| NCT number | NCT00117182 |
|---|---|
| Title | Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD |
| Official title | A Phase II Study to Investigate Mannitol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD |
| Lead sponsor | Syntara, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Diseases, Obstructive |
| Intervention type | Drug |
| Interventions | Dry powder mannitol, Budesonide 400mcg administered via turbuhaler, Ipratropium bromide 80mcg, Salbutamol 400mcg |
| Enrollment | 140 |
| Start date | Jul 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Jul 4, 2005 |
| Last update posted | Apr 20, 2016 |
| Countries | Australia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: